Tough Times for Drug Intermediates

Scott, Alex
September 2003
Chemical Week;9/24/2003, Vol. 165 Issue 33, p56
Trade Publication
Deals with the market condition of the pharmaceutical intermediates business, as of September 2003. Problems facing traditional custom synthesis; Information on the employee downsizing and operating costs reduction move of several chemical companies, including Lonza, Rhodia, and Clariant; Status of the custom biologic business.


Related Articles

  • Custom Firms Focus on Cost-Cutting Efforts. Scott, Alex // Chemical Week;9/24/2003, Vol. 165 Issue 33, p62 

    Reports on the cost-cutting efforts of pharmaceutical intermediates producers in the U.S. in 2003. Factors attributed to the declining market condition of the industry; Cost-cutting and employee downsizing move of Lonza, Rhodia, and Clariant; Forecast on the sales performance of the company DSM...

  • Clariant and Rhodia Increase Selling Prices to Offset Mounting Raw Material Costs. Walsh, Kerri // Chemical Week;12/12/2007, Vol. 169 Issue 40, p15 

    The article reports on the plan by specialty chemical producers Clariant and Rhodia to implement global price increases to offset rising costs and boost margins. Both companies say they have reduced operating costs during the past few years, but that those actions have not been enough to offset...

  • Speciality chemicals scenario.  // Chemical Business;Nov98, Vol. 12 Issue 11, p6 

    Reports on the specialty chemicals market in 1998. Competitive edge of European global specialty chemical players such as Imperial Chemical Industries, Clariant and Rhodia; Slowness of the specialty chemical companies in the United States in making large scale acquisitions.

  • specialties.  // Chemical Week;11/13/2002, Vol. 164 Issue 45, p31 

    Presents news briefs on the specialty chemical industry, as of November 13, 2002. Reorganization plan of Clariant for its pigments and additives division; Line of defoamers introduced by Rhodia in the chemical market; Selection of Praxair Distribution as U.S. and Canadian distributor for a...

  • European earnings offer mixed bag. Milmo, Sean // Chemical Market Reporter;11/02/98, Vol. 254 Issue 18, p8 

    Reports on the financial performances of chemical companies in Europe in the first nine months of 1998. Increase in pretax earnings by Rhodia; Drop in sales by Clariant; Increase in sales by DSM due to the strength of its takeover of Gist-brocades in early 1998.

  • Specialty Producers Report a Rebound in Sales.  // Chemical Market Reporter;5/6/2002, Vol. 261 Issue 18, p6 

    Highlights European specialty chemicals companies that posted a rebound in sales and profits in the first quarter of 2002 after being hit by poor demand in the fourth quarter of 2001. Rhodia; Clariant; ICI; DSM.

  • European Chemical Companies See New Ways to Innovate. Milmo, Sean // Chemical Market Reporter;4/8/2002, Vol. 261 Issue 14, pFR15 

    Focuses on the decision of large specialty chemical companies to shift to a decentralized approach to research and development (R & D). Purpose of R & D programs; Percentage of BASF sales that are in specialty chemicals; Innovation forums at Clariant; Cornerstone of Rhodia's competitiveness.

  • Lonza to Spend $200 Million on Fine Chemical Capacity in China. Scott, Alex // Chemical Week;4/12/2006, Vol. 168 Issue 13, p16 

    This article deals with the plan of Lonza to build an undisclosed number of fine chemical manufacturing facilities in China. The investment will focus on expanding the production site of the company at Nansha near Guangzhou. The investment program will entail a multipurpose active...

  • Raising the Bar in Custom Manufacturing. Naude, Alice // Chemical Market Reporter;08/21/2000, Vol. 258 Issue 8, pFR19 

    Focuses on the merger of companies in the pharmaceutical industry which changed the market for custom manufacturing. Terms of the acquisition agreement between Rhodia and ChiRex; Value of Evotec Biosystems' acquisition of Oxford Asymmetry; Acquisition of BTP by Clariant.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics